Cost-effectiveness of Intravenous Iron Sucrose for Treating Anemia in Pregnancy: A Model-based Cost Utility Analysis

Background

Anemia is one of the most common nutritional deficiencies among pregnant women, often causing adverse maternal and fetal outcomes. While oral iron has been the primary strategy for managing anemia, however, issues related to compliance and absorption have limited its effectiveness. Intravenous iron sucrose has emerged as a potential alternative, but its cost-effectiveness remains underexplored.